Sanofi India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India's two promoters — Sanofi SA (Paris) and Hoechst GmbH (Frankfurt) — have each filed a declaration under SEBI's Takeover Regulations confirming that neither they nor any person acting in concert with them has created any encumbrance (pledge, lien, or charge) on their equity shares in Sanofi India as of 31 December 2024 and up to the date of the filing (3 January 2025). This is a routine annual/periodic compliance disclosure required from promoters, not a transaction announcement. No share sale, purchase, or pledge activity is reported in this filing.
This is a neutral compliance filing with no material impact on shareholders or the stock price. It simply reassures investors that the promoters' holdings remain free of any pledge or encumbrance, which is a positive indicator of promoter stability and confidence.